FDA Anesthetic and Life Support Drugs Advisory Committee
Will meet July 20 to discuss "preclinical guidelines for reproduction studies for safety evaluation of neuromuscular blocking agents and general anesthetics for human use," according to June 22 Federal Register notice. Meeting will take place, beginning at 8:30 a.m., at Conference Rooms D&E, FDA's Parklawn Building, Rockville, Md.
You may also be interested in...
In this week’s podcast, Medtech Insight's managing editor Marion Webb has an update from the virtual HLTH panel discussions on telehealth and robotics. Deputy editor Reed Miller discusses trial results from Boston Scientific’s next-generation Accurate neo2 self-expanding aortic valve presented during the Transcatheter Cardiovascular Therapeutics (TCT) meeting.
The rare disease-focused firm will pay $90m up front to acquire Orphan Technologies and its Phase I/II enzyme replacement therapy for homocystinuria. Earnouts up to $427m are possible as well.